What is Gyre Therapeutics, Inc.'s free cash flow yield?

Gyre Therapeutics, Inc. (GYRE) reported free cash flow yield of 0.5% in Q1 2026.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Gyre Therapeutics, Inc. GYRE Free cash flow yield

Free cash flow yield at other companies

Eli LillyLLY

1.4%+0.9pp

Madrigal Pharmaceuticals, Inc.MDGL

-4.9%-1.3pp

Theravance BiopharmaTBPH

25.2%+23.0pp

Zevra Therapeutics, Inc.ZVRA

-9.3%-3.7pp

LQD

Liquidia CorporationLQDA

-5.3%-1.9pp

BridgeBio PharmaBBIO

-3.1%—

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

free cash flow/market cap=0.5%

Based on trailing twelve months.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s free cash flow yield?: Gyre Therapeutics, Inc. (GYRE) reported free cash flow yield of 0.5% in Q1 2026.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.